« Development of a flow cytometry-based method to detect neutralising antibodies in SARS-CoV-2 infection  ». One Health & Risk Management (avril 27, 2023): 41. Consulté le juillet 11, 2026. https://ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/440.